Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bortezomib resistance in multiple myeloma is associated with increased serine synthesis
Esther A. Zaal, Wei Wu, Gerrit Jansen, et al.
Cancer & Metabolism (2017) Vol. 5, Iss. 1
Open Access | Times Cited: 143

Showing 1-25 of 143 citing articles:

Mitochondrial metabolism promotes adaptation to proteotoxic stress
Peter Tsvetkov, Alexandre Detappe, Kai Cai, et al.
Nature Chemical Biology (2019) Vol. 15, Iss. 7, pp. 681-689
Open Access | Times Cited: 427
Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC
Lai Wei, Derek Lee, Cheuk‐Ting Law, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 331
The proteasome and proteasome inhibitors in multiple myeloma
Sara Gandolfi, Jacob P. Laubach, Teru Hideshima, et al.
Cancer and Metastasis Reviews (2017) Vol. 36, Iss. 4, pp. 561-584
Closed Access | Times Cited: 299
The Influence of Metabolism on Drug Response in Cancer
Esther A. Zaal, Celia R. Berkers
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 223
Amino Acid Metabolism in Cancer Drug Resistance
Hee-Chan Yoo, Jung Min Han
Cells (2022) Vol. 11, Iss. 1, pp. 140-140
Open Access | Times Cited: 74
Inhibition of phosphoglycerate dehydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cells
Jinxiang Wang, Leli Zeng, Nisha Wu, et al.
Drug Resistance Updates (2023) Vol. 70, pp. 100985-100985
Open Access | Times Cited: 51
Positioning of proteasome inhibitors in therapy of solid malignancies
Margot S. F. Roeten, Jacqueline Cloos, Gerrit Jansen
Cancer Chemotherapy and Pharmacology (2017) Vol. 81, Iss. 2, pp. 227-243
Open Access | Times Cited: 129
Metabolic Reprogramming of Chemoresistant Cancer Cells and the Potential Significance of Metabolic Regulation in the Reversal of Cancer Chemoresistance
Xun Chen, Shangwu Chen, Dongsheng Yu
Metabolites (2020) Vol. 10, Iss. 7, pp. 289-289
Open Access | Times Cited: 98
Impact of cancer metabolism on therapy resistance – Clinical implications
Ana Cristina Gonçalves, Elena Richiardone, Joana Jorge, et al.
Drug Resistance Updates (2021) Vol. 59, pp. 100797-100797
Open Access | Times Cited: 90
Metabolic Reprogramming in Anticancer Drug Resistance: A Focus on Amino Acids
Erica Pranzini, Elisa Pardella, Paolo Paoli, et al.
Trends in cancer (2021) Vol. 7, Iss. 8, pp. 682-699
Open Access | Times Cited: 87
SHMT2-mediated mitochondrial serine metabolism drives 5-FU resistance by fueling nucleotide biosynthesis
Erica Pranzini, Elisa Pardella, Livio Muccillo, et al.
Cell Reports (2022) Vol. 40, Iss. 7, pp. 111233-111233
Open Access | Times Cited: 57
Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma
Yuen Lam Dora Ng, Evelyn Ramberger, Stephan Bohl, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 45
PHGDH: a novel therapeutic target in cancer
Chae Min Lee, Yeseong Hwang, Minki Kim, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 7, pp. 1513-1522
Open Access | Times Cited: 10
LncRNA PDIA3P interacts with c-Myc to regulate cell proliferation via induction of pentose phosphate pathway in multiple myeloma
Xiangchou Yang, Haihao Ye, Muqing He, et al.
Biochemical and Biophysical Research Communications (2018) Vol. 498, Iss. 1, pp. 207-213
Closed Access | Times Cited: 78
The Role of D-3-Phosphoglycerate Dehydrogenase in Cancer
Xiaoya Zhao, Jianfei Fu, Jinlin Du, et al.
International Journal of Biological Sciences (2020) Vol. 16, Iss. 9, pp. 1495-1506
Open Access | Times Cited: 68
Metabolic Features of Multiple Myeloma
Chaima El Arfani, Kim De Veirman, Ken Maes, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 4, pp. 1200-1200
Open Access | Times Cited: 63
A metabolic switch in proteasome inhibitor-resistant multiple myeloma ensures higher mitochondrial metabolism, protein folding and sphingomyelin synthesis
Lenka Bešše, Andrej Bešše, Max Mendez-Lopez, et al.
Haematologica (2019) Vol. 104, Iss. 9, pp. e415-e419
Open Access | Times Cited: 60
Phosphoglycerate dehydrogenase promotes proliferation and bortezomib resistance through increasing reduced glutathione synthesis in multiple myeloma
Xuan Wu, Jiliang Xia, Jingyu Zhang, et al.
British Journal of Haematology (2020) Vol. 190, Iss. 1, pp. 52-66
Open Access | Times Cited: 55
High Fructose Drives the Serine Synthesis Pathway in Acute Myeloid Leukemic Cells
Sangmoo Jeong, Angela Maria Savino, Rachel Chirayil, et al.
Cell Metabolism (2020) Vol. 33, Iss. 1, pp. 145-159.e6
Open Access | Times Cited: 55
Mitochondrial Functions, Energy Metabolism and Protein Glycosylation are Interconnected Processes Mediating Resistance to Bortezomib in Multiple Myeloma Cells
Daniele Tibullo, Cesarina Giallongo, Alessandra Romano, et al.
Biomolecules (2020) Vol. 10, Iss. 5, pp. 696-696
Open Access | Times Cited: 50
Emerging Therapeutic Strategies to Overcome Drug Resistance in Multiple Myeloma
Lorraine N. Davis, Daniel W. Sherbenou
Cancers (2021) Vol. 13, Iss. 7, pp. 1686-1686
Open Access | Times Cited: 45
CDK7 controls E2F- and MYC-driven proliferative and metabolic vulnerabilities in multiple myeloma
Yao Yao, Jessica Fong Ng, Woojun D. Park, et al.
Blood (2023)
Open Access | Times Cited: 21
The future of myeloma precision medicine: integrating the compendium of known drug resistance mechanisms with emerging tumor profiling technologies
Taylor Harding, Linda B. Baughn, Shaji Kumar, et al.
Leukemia (2019) Vol. 33, Iss. 4, pp. 863-883
Closed Access | Times Cited: 52
Metabolomics study of oral cancers
Xun Chen, Dongsheng Yu
Metabolomics (2019) Vol. 15, Iss. 2
Closed Access | Times Cited: 51
Metabolic alterations and the potential for targeting metabolic pathways in the treatment of multiple myeloma
Dustin Rizzieri, Barry Paul, Yubin Kang
Journal of Cancer Metastasis and Treatment (2019) Vol. 2019
Open Access | Times Cited: 51
Page 1 - Next Page

Scroll to top